uBiome

SEC Charges Co-Founders of San Francisco Biotech Company With $60 Million Fraud

Retrieved on: 
Thursday, March 18, 2021
Citizen science, Genetic genealogy, Microbiology, Microbiomes, uBiome, Branches of biology, Apte, Richman, Biology, Articles

"According to the complaint, Richman and Apte portrayed the company as having a strong track record of receiving health insurance reimbursement for its clinical tests, which purportedly could detect microorganisms and assist in diagnosing disease.

Key Points: 
  • "According to the complaint, Richman and Apte portrayed the company as having a strong track record of receiving health insurance reimbursement for its clinical tests, which purportedly could detect microorganisms and assist in diagnosing disease.
  • According to the complaint, Richman and Apte were each enriched by millions through selling their own uBiome shares during the fraudulent fundraising round.
  • "We allege that Richman and Apte touted uBiome as a successful and fast-growing biotech pioneer while hiding the fact that the company's purported success depended on deceit,"said Erin Schneider, Director of the SEC's San Francisco Regional Office.
  • Postal Inspection Service, Defense Criminal Investigative Service, and Department of Health and Human Services Office of Inspector General.

Psomagen-Macrogen Consortium Acquires All Patents and Data From US Company uBiome

Retrieved on: 
Thursday, January 2, 2020
Biotechnology, Genetics, Health, Branches of biology, Microbiology, Microbiomes, Biology, Organisms, Bacteriology, Citizen science, Genetic genealogy, uBiome, Microbiota, Draft:Elisabeth Bik, Pharmacomicrobiomics

On January 2nd, the Psomagen - Macrogen Consortium announced the acquisition of all key assets of US company uBiome.

Key Points: 
  • On January 2nd, the Psomagen - Macrogen Consortium announced the acquisition of all key assets of US company uBiome.
  • The acquisition includes a microbiome patent portfolio comprising 246 patents (60 registered US patents and 186 applications), anonymized microbiome data, nearly 300,000 samples, and laboratory equipment from uBiomes laboratory in San Francisco.
  • uBiome was a microbiome company based in San Francisco, known for its unique and competitive market presence in the field of sequencing on the microbiomes 16S rRNA gene.
  • The companys patent portfolio in the field is rated the third best in the world, and the amount of the microbiome data the company had accumulated is the biggest in the world.

uBiome Appoints John Rakow as Interim Chief Executive Officer

Retrieved on: 
Wednesday, May 1, 2019
Microbiology, Branches of biology, Citizen science, Genetic genealogy, uBiome, Cision, Rakow, Biology, Companies

SAN FRANCISCO, May 1, 2019 /PRNewswire-PRWeb/ -- uBiome, the leader in microbial genomics, today announced that its Board of Directors has appointed John Rakow, the Company's General Counsel, as Interim Chief Executive Officer of uBiome, effective immediately.

Key Points: 
  • SAN FRANCISCO, May 1, 2019 /PRNewswire-PRWeb/ -- uBiome, the leader in microbial genomics, today announced that its Board of Directors has appointed John Rakow, the Company's General Counsel, as Interim Chief Executive Officer of uBiome, effective immediately.
  • There will also be an independent investigation into uBiome's billing practices to be overseen by a Special Committee of the Board.
  • Mr. Rakow, who joined uBiome in fall 2018, is a seasoned attorney with more than 35 years of experience providing legal counsel and leadership as a member of senior management teams of both public and privately-held companies.
  • uBiome combines precision sequencing with machine learning and artificial intelligence to develop wellness products, clinical tests, and therapeutic targets.

uBiome Appoints Dr. Caldwell Esselstyn, MD, Director of the Cardiovascular Disease Prevention and Reversal Program, to its Medical Advisory Board

Retrieved on: 
Thursday, April 4, 2019
Vegetarians, Branches of biology, Caldwell Esselstyn, Health, uBiome, Esselstyn, Nutrition

SAN FRANCISCO, April 04, 2019 /PRNewswire-PRWeb/ --uBiome announces the addition of Dr. Caldwell Esselstyn, MD, Director of the Cardiovascular Disease Prevention and Reversal Program at the Cleveland Clinic Wellness Institute, to its Medical Advisory Board.

Key Points: 
  • SAN FRANCISCO, April 04, 2019 /PRNewswire-PRWeb/ --uBiome announces the addition of Dr. Caldwell Esselstyn, MD, Director of the Cardiovascular Disease Prevention and Reversal Program at the Cleveland Clinic Wellness Institute, to its Medical Advisory Board.
  • Joining the board of leading scientists and doctors from around the world, Dr. Esselstyn will bring to uBiome expertise on strategies to reverse cardiovascular disease using dietary intervention.
  • "We are in awe of his contribution to improving our nation's understanding of health and disease, and are truly honored to have him join uBiome's board of medical advisors."
  • Since 2009, Dr. Esselstyn has been a Preventative Medicine Consultant and the Director of Cardiovascular Disease Prevention and Reversal Program at the Cleveland Clinic Wellness Institute.

uBiome Awards Grant to the Institute of Health and Environmental Research to Study Influence of Diet on Gut Microbiome in Autism Spectrum Disorder

Retrieved on: 
Tuesday, April 2, 2019
Branches of biology, Microbiology, Medical specialties, Biology, Bacteriology, Citizen science, Genetic genealogy, uBiome, Microbiota, Autism

"We are excited to support the Institute of Health and Environmental Research for this research."

Key Points: 
  • "We are excited to support the Institute of Health and Environmental Research for this research."
  • About the grant, Dr. Fluegge said, "The Institute of Health and Environmental Research is proud to partner with uBiome to carry out an original research project at the nexus of agriculture and health.
  • Our collaboration connects the unconventional consumption of functionally-active foods with the restoration of microbiome health and diversity, which may alleviate symptoms of mental health disorders, like autism.
  • Awards include patented microbiome sequencing kits, as well as research support in study design, planning, sample collection, and analysis.

uBiome Awarded Eighth Patent for the Characterization of Skin Related Conditions

Retrieved on: 
Monday, April 1, 2019
RTT, Organ systems, Branches of biology, Medical specialties, Acne, uBiome, Dandruff, Dermatitis, Photosensitivity

SAN FRANCISCO, April 1, 2019 /PRNewswire-PRWeb/ -- uBiome announces the issue of patent number 10,169,541 entitled "Method and System for Characterizing Skin Related Conditions" by the US Patent and Trademark Office on January 1, 2019 with a priority date of October 21, 2014.

Key Points: 
  • SAN FRANCISCO, April 1, 2019 /PRNewswire-PRWeb/ -- uBiome announces the issue of patent number 10,169,541 entitled "Method and System for Characterizing Skin Related Conditions" by the US Patent and Trademark Office on January 1, 2019 with a priority date of October 21, 2014.
  • The patented technology involves characterizing a skin-related condition such as eczema, dry skin, photosensitivity, dandruff, and acne, among others.
  • Further, the patent involves developing a therapy to prevent or ameliorate skin-related conditions by analyzing biological samples from uBiome's patented kits.
  • Together, these potential impacts could improve the treatment and management of skin-related conditions in an individualized and population-wide manner.

uBiome Awards Grant to The Australian National University to Study the Association Between Personality Disorders and the Gut Microbiome

Retrieved on: 
Thursday, March 21, 2019
Branches of biology, Microbiology, Bacteriology, Biology, Environmental microbiology, Citizen science, Genetic genealogy, uBiome, Microbiota, Gut flora, Pharmacomicrobiomics, Human microbiota

Data collected from the study will include microbiome composition from uBiome's patented kits, physical and mental health assessment, saliva samples, and self-reported mood symptoms and food intake.

Key Points: 
  • Data collected from the study will include microbiome composition from uBiome's patented kits, physical and mental health assessment, saliva samples, and self-reported mood symptoms and food intake.
  • "While research has proven a correlation between mood and the gut microbiome, this is the first study focused particularly on the relationship between Borderline Personality Disorder and the gut microbiome," said Jessica Richman, PhD, co-founder and CEO of uBiome.
  • "We are proud to support The Australian National University for this exciting study."
  • Awards include patented microbiome sequencing kits, as well as research support in study design, planning, sample collection, and analysis.

Peer-Reviewed Paper in Frontiers in Bioengineering and Biotechnology Reveals that uBiome Has the Largest Patent Portfolio in the Microbiome Space

Retrieved on: 
Monday, March 18, 2019
Branches of biology, Microbiology, Biology, Organisms, Citizen science, Genetic genealogy, uBiome, Bacteriology, Patent, Microbiota

Richman, Apte, and Almonacid hold the first, second, and third spots as top microbiome inventors in terms of portfolio size and they hold the second, third, and fourth spots in terms of patent quality.

Key Points: 
  • Richman, Apte, and Almonacid hold the first, second, and third spots as top microbiome inventors in terms of portfolio size and they hold the second, third, and fourth spots in terms of patent quality.
  • This study provides a case study of how in-depth patent analyses can identify early indicators of technology and investment trends from large patent databases.
  • The patents protect uBiome's sequencing-based microbiome tests as well as the technical platforms needed to analyze and disseminate them.
  • uBiome combines its patented proprietary precision sequencing with machine learning and artificial intelligence to develop wellness products, clinical tests, and therapeutic targets.

uBiome Launches Research Partnership with University of Louisville Physicians to Investigate the Microbiome as a Predictor of Clinical Response to IBD Therapies

Retrieved on: 
Thursday, March 7, 2019
Branches of biology, Microbiology, Bacteriology, Biology, Environmental microbiology, Citizen science, Genetic genealogy, uBiome, Human microbiota, Microbiota, Inflammatory bowel disease, Human Microbiome Project

"We are proud to support Dr. Wuerth and Dr. Dryden's mission to uncover the associations of the microbiome in clinical response to therapies for IBD."

Key Points: 
  • "We are proud to support Dr. Wuerth and Dr. Dryden's mission to uncover the associations of the microbiome in clinical response to therapies for IBD."
  • If microbiota does in fact act as a predictor, microbiome testing could be performed prior to selecting a certain agent.
  • A sufferer of IBD himself, he founded the popular website IBDwatch.org to broadcast news and research pertaining to IBD to both physicians and patients.
  • Through its Clinical Research Initiative, uBiome provides microbiome research support in study design, planning, sample collection and sequencing, and bioinformatic analysis to researchers.

uBiome Appoints Dr. Aubrey Tauer, Veterinary Epidemiologist, to its Scientific Advisory Board

Retrieved on: 
Wednesday, March 6, 2019
Branches of biology, Citizen science, Genetic genealogy, Microbiology, uBiome, Veterinary physician, Doctor, Tauer, Biology

SAN FRANCISCO, March 6, 2019 /PRNewswire-PRWeb/ -- uBiome, the leader in microbial genomics, announces the addition of Dr. Aubrey Tauer, DVM, MPH, DACVPM, Founder and President of Cra Earth, to its Scientific Advisory Board.

Key Points: 
  • SAN FRANCISCO, March 6, 2019 /PRNewswire-PRWeb/ -- uBiome, the leader in microbial genomics, announces the addition of Dr. Aubrey Tauer, DVM, MPH, DACVPM, Founder and President of Cra Earth, to its Scientific Advisory Board.
  • Joining the board of leading scientists and doctors from around the world, Dr. Tauer will bring to uBiome a diverse background in veterinary public health, disease ecology, and microbiology.
  • "For that reason and more, we are thrilled to have Dr. Tauer join the uBiome Scientific Advisory Board."
  • Dr. Tauer completed her Doctorate in Veterinary Medicine at the University of Minnesota-Twin Cities.